SCHEMBL6290352

SCHEMBL6290352

Cc1[nH]c2ccccc2c1CC(=O)[C@](N)(Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(Cc3c[nH]c4ccccc34)C(=O)Cc3c(C)[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@](N)(Cc3c[nH]c4ccccc34)C(=O)Cc3c(C)[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
MEN1 O00255 2/20 0.40
ALOX12 P18054 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RUVBL1 Q9Y265 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7040124 0.91 AKR1C2 (0.44) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL6287787 0.88 L3MBTL1 (0.44) MAPTALDH1A1KDM4EMEN1ALOX12
SCHEMBL6290659 0.84 MAPT (0.45) MAPTALDH1A1GAAKDM4ECASP1
SCHEMBL6287338 0.83 MAPT (0.43) MAPTALDH1A1GAAKDM4ECASP1
SCHEMBL6287910 0.82 KDM4E (0.42) MAPTALDH1A1GAAKDM4ECASP1
Hydrochloric Acid SCHEMBL6287751 0.81 KDM4E (0.42) MAPTALDH1A1GAAKDM4ECASP1
SCHEMBL6288048 0.81 LMNA (0.39) MAPTALDH1A1MEN1ALOX12KMT2A
SCHEMBL6287689 0.80 L3MBTL1 (0.44) MAPTALDH1A1KDM4EMEN1ALOX12
SCHEMBL6287870 0.80 MAPT (0.40) MAPTALDH1A1GAAKDM4ECASP1
SCHEMBL7030590 0.79 MTNR1A (0.41) MAPTALDH1A1GAAKDM4ECASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK MAPT 4866/4885ALDH1A1 2042/4885GAA 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.